Aims and Scope of Biochemical Pharmacology
Biochemical Pharmacology is a peer-reviewed medical journal published by Elsevier. It covers research on the pharmacodynamics and pharmacokinetics of drugs and non-therapeutic xenobiotics. The editor-in-chief is S. J. Enna, University of Kansas Medical Center, Kansas City. Less
Key Metrics
CiteScore 

9.3
Eigenfactor 

0.01 - 0.05
Impact Factor 

5 - 10
Scite Index 

0.94 5-Year SI

SJR 

Q1Biochemistry

SNIP 

1.25
Recommended pre-submission checks
Powered by 

Topics Covered on Biochemical Pharmacology
Biochemical Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | PERGAMON-ELSEVIER SCIENCE LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1958 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Biochemical Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Biochemical Pharmacology
Ranolazine exerts cardioprotection through attenuating mitochondrial dynamic imbalance in trastuzumab-induced cardiotoxicity in rats.
- 1 Aug 2026
- Biochemical pharmacology
NPTX2 accelerates cell cycle progression, activates EMT, and regulates glycolytic metabolic pathways to promote clear cell renal cell carcinoma progression.
- 1 Aug 2026
- Biochemical pharmacology
Fangchinoline derivative LYY-34 suppresses TNBC by inhibiting BLM DNA helicase from unfolding of c-MYC promoter G-quadruplex DNA.
- 1 Aug 2026
- Biochemical pharmacology
Retraction notice to "Omentin-1 attenuates salt-sensitive hypertension via GRK4/AT1R downregulation mediated by the ROS/c-Myc pathway" [Biochem. Pharmacol. 243 (2026) 117489
- 1 Aug 2026
- Biochemical pharmacology
Discovery of novel CSF1R inhibitor for triple-negative breast cancer (TNBC) treatment through TAMs reprogramming.
- 1 Aug 2026
- Biochemical pharmacology
Cannabinoids and the autophagy-related signaling in brain tumors: from mechanistic insights to therapeutic frontiers in glioblastoma.
- 1 Aug 2026
- Biochemical pharmacology
Ranolazine exerts cardioprotection through attenuating mitochondrial dynamic imbalance in trastuzumab-induced cardiotoxicity in rats.
- 1 Aug 2026
- Biochemical pharmacology
NPTX2 accelerates cell cycle progression, activates EMT, and regulates glycolytic metabolic pathways to promote clear cell renal cell carcinoma progression.
- 1 Aug 2026
- Biochemical pharmacology
Fangchinoline derivative LYY-34 suppresses TNBC by inhibiting BLM DNA helicase from unfolding of c-MYC promoter G-quadruplex DNA.
- 1 Aug 2026
- Biochemical pharmacology
Retraction notice to "Omentin-1 attenuates salt-sensitive hypertension via GRK4/AT1R downregulation mediated by the ROS/c-Myc pathway" [Biochem. Pharmacol. 243 (2026) 117489
- 1 Aug 2026
- Biochemical pharmacology
Discovery of novel CSF1R inhibitor for triple-negative breast cancer (TNBC) treatment through TAMs reprogramming.
- 1 Aug 2026
- Biochemical pharmacology
Cannabinoids and the autophagy-related signaling in brain tumors: from mechanistic insights to therapeutic frontiers in glioblastoma.
- 1 Aug 2026
- Biochemical pharmacology